<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2011-09-01">1 st Sep 2011</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">T</forename><surname>Narayanan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">)</forename><surname>Khan</surname></persName>
						</author>
						<author>
							<persName><roleName>Mulloy, B. &amp;</roleName><forename type="first">S</forename><forename type="middle">J</forename><surname>Perkins</surname></persName>
						</author>
						<author>
							<persName><forename type="first">)</forename><surname>Li</surname></persName>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2011-09-01">1 st Sep 2011</date>
						</imprint>
					</monogr>
					<idno type="MD5">50F4F3F60C8BE38B5E1F371B9FA17F8D</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-22T21:28+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Factor H (FH) with 20 short complement regulator (SCR) domains is a major serum regulator of complement, and is associated with diseases including age-related macular degeneration and atypical haemolytic uraemic syndrome. Heparin binding to FH at SCR-7 and SCR-20 is an analogue of FH binding to glycosaminoglycan-coated host cell surfaces. To elucidate the solution structures of heparin fragments dp6-dp36 bound to intact FH (where dp stands for degree of polymerisation), FH-heparin mixtures were studied by X-ray scattering and analytical ultracentrifugation. The X-ray radius of gyration R G of FH slightly decreased from 8.4 to 7.3 nm for dp6 and dp12, showing that heparin blocked FH self-association. In the presence of dp18 to dp36, the R G increased significantly from 10.4 to 11.7 nm, and the maximum lengths of FH increased from 35 nm to 40 nm, indicating the formation of compact oligomers. In contrast to the 12-15% of oligomers for free FH, ultracentrifugation showed that heparin induced up to 63% of structurally welldefined FH oligomers ranging from dimer to decamer. This corresponds to a moderate dissociation constant K D of about 0.5 µM. Surface plasmon resonance of FH-dp32 mixtures gave a comparable K D of 2.7 µM.</p><p>Molecular modelling of FH molecules cross-linked by heparin molecules explained the sedimentation coefficients of the oligomers without a need to invoke major conformational changes in FH. We obtain the first molecular view of the bivalent binding of FH to host cell surfaces at two independent sites, and this provides novel insights on complement-mediated immune disease. Publication: Li, K. &amp; Perkins, S. J. (2011) Complement C3u interacts independently with complement Factor H at two sites: implications for complement regulation. Submitted.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body/>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
